ANI Pharmaceuticals | ANIP - Ebit





Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD 7.12M 42.91M 2026-03
Canopy Growth CAD -145.65M 132.99M 2026-03
Eli Lilly USD 12.46B 2.68B 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.18B 118M 2026-03
Omeros USD -48.15M 7.25M 2023-09
Perrigo USD 33.6M 50.8M 2026-03
Sun Pharmaceuticals INR 35.57B 802.7M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06